HIGH-RISK CANCER
Clinical trials for HIGH-RISK CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK CANCER trials appear
Sign up with your email to follow new studies for HIGH-RISK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation before chemo: a new immune booster for aggressive breast cancer?
Disease control OngoingThis study tests whether giving a small dose of targeted radiation to the tumor before standard chemotherapy can prime the immune system to better attack high-risk breast cancer. About 40 adults with locally advanced breast cancer will receive three radiation treatments, then pro…
Matched conditions: HIGH-RISK CANCER
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
Patients choose their own treatment in landmark myelofibrosis study
Disease control OngoingThis study compares a stem cell transplant to the best available non-transplant treatments for people with high-risk myelofibrosis, a serious bone marrow cancer. About 90 participants will choose which treatment they prefer, and researchers will track survival and quality of life…
Matched conditions: HIGH-RISK CANCER
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Will High-Risk smokers show up for lung scans? french study aims to find out
Knowledge-focused OngoingThis study tracks 126 adults aged 50 to 74 who are at high risk for lung cancer due to heavy smoking. The goal is to see how many actually complete their low-dose CT scans as part of a screening program. Researchers also look at how many refuse screening, quit smoking, and the ra…
Matched conditions: HIGH-RISK CANCER
Phase: NA • Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC